KSC Equity Snapshot
005690 Weekly Equity Report
Pharmicell Co., Ltd.
What the company does
Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to improve the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC to treat hepatic insufficiency; Cellgram_ED for treating impotence; and Hearticellgram_AMI, a cardiac disease drug. It develops and produces intermediates of raw material medicines, such as nucleosides and mPEGs; and low dielectric constant material, eco-friendly …
What the weekly tape is saying
005690 closed the latest completed week at 14,690 KRW. The 4-week return is -14.2% and the 12-week return is -9.0%. Trend Signal is inactive, Market Dynamics is -0.90. Setup signature: Risk-first tape with a 18/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 15,854 KRW
- Vs Trend Line
- -7.3%
- Fair Value
- 9,547 KRW
- Vs Fair Value
- 53.9%
- 52W High
- 21,150 KRW
- 52W Low
- 10,325 KRW
- Drawdown
- -30.5%
- Range Position
- 40.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 49
- 52W Active Breadth
- 94.2%
- Sector Scope
- KR Healthcare
- Sector Rank
- 1 of 63
- Sector Percentile
- 100.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 42 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Biotechnology
- Tracked Peers
- 10
- 4W Rank
- 8 of 10
- Avg 1W
- -0.9%
- Avg 4W
- -11.2%
- Trend Breadth
- 0.0%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.90
- 4W MD Change
- -223.5%
- Relative Strength
- -44.87
- 4W RS Change
- -31.8%
- Expectation
- Undecided
- Probability
- 49.31%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 3.4M
- 13W Average
- 4.7M
- 52W Average
- 8.8M
- Vs 13W
- 0.7x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.5%
- 52W Volatility
- 8.6%
- Upside Weeks
- 27
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 7.6% / -6.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- KRW
- Market Cap
- 897.1B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 14,690 KRW | 10.2% | 15,854 KRW | 9,547 KRW | -0.90 | -44.87 | 3.4M | Off |
| 5 Jun 2026 | 13,330 KRW | -11.1% | 15,945 KRW | 9,502 KRW | -0.55 | -50.78 | 2.6M | Off |
| 29 May 2026 | 15,000 KRW | -9.7% | 16,075 KRW | 9,473 KRW | 0.03 | -47.47 | 3.2M | On |
| 22 May 2026 | 16,610 KRW | -3.0% | 16,139 KRW | 9,434 KRW | 0.47 | -38.08 | 3.6M | On |
| 15 May 2026 | 17,130 KRW | -11.3% | 16,078 KRW | 9,385 KRW | 0.73 | -34.04 | 5.9M | On |
| 8 May 2026 | 19,320 KRW | 6.7% | 15,943 KRW | 9,333 KRW | 0.87 | -26.46 | 7.6M | On |
| 1 May 2026 | 18,110 KRW | -0.9% | 15,718 KRW | 9,267 KRW | 0.73 | -22.36 | 7.5M | On |
| 24 Apr 2026 | 18,280 KRW | -2.2% | 15,523 KRW | 9,210 KRW | 0.50 | -20.90 | 4.8M | On |
| 17 Apr 2026 | 18,690 KRW | 11.6% | 15,310 KRW | 9,151 KRW | 0.42 | -15.93 | 7.8M | On |
| 10 Apr 2026 | 16,740 KRW | 12.0% | 15,111 KRW | 9,090 KRW | 0.20 | -20.80 | 4.4M | On |
| 3 Apr 2026 | 14,940 KRW | -11.7% | 14,944 KRW | 9,045 KRW | 0.11 | -23.39 | 3.3M | On |
| 27 Mar 2026 | 16,920 KRW | 4.8% | 14,823 KRW | 9,010 KRW | -0.01 | -14.67 | 4.1M | On |
| 20 Mar 2026 | 16,150 KRW | -1.6% | 14,629 KRW | 8,959 KRW | -0.10 | -23.73 | 3.5M | On |
| 13 Mar 2026 | 16,420 KRW | 13.2% | 14,451 KRW | 8,914 KRW | -0.15 | -18.94 | 5.3M | On |